Management of Patients With Skin Cancers: Basal Cell Carcinoma and Melanoma

November 4, 2016

Learning Objectives

  • Demonstrate increased understanding of the MOAs of targeted and immunotherapy agents used in the treatment of advanced/metastatic melanoma and/or basal cell carcinoma, including the impact these unique agents have on patient outcomes
  • Apply new skill sets to guide and manage treatment expectations of patients and their families
  • Recognize and manage adverse events that occur with use of targeted therapies and immunotherapies in the treatment of advanced/metastatic melanoma and/or basal cell carcinoma
  • Discuss the pivotal role and necessary expertise of the AP as a vital part of the collaborative oncology team treating these skin cancers
Course summary
Available credit: 
  • 0.75 ACPE
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
  • 0.75 ANCC
Course opens: 
11/04/2016
Course expires: 
06/08/2017
Event starts: 
11/04/2016 - 10:35am
Event ends: 
11/04/2016 - 11:20am
Cost:
$0.00
Rating: 
0
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 0.75 ACPE
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
  • 0.75 ANCC

Price

Cost:
$0.00
Please login or register to take this course.